Condition (MeSH)
Endoleak
ClinicalTrials.gov lists 28 trials for Endoleak or a narrower condition beneath it. TripleMed B.V. has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
28 of the 28 trials are tagged with Endoleak itself; the rest are tagged with a narrower condition beneath it.
When did Endoleak trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2019 | 1 |
| 2018 | 3 |
| 2016 | 1 |
| 2014 | 2 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Endoleak trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 16 |
| Observational | 12 |
How many Endoleak trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Completed | 15 |
| Terminated | 3 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Endoleak trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| TripleMed B.V. | 3 |
| Endologix | 1 |
| Lifetech Scientific (Shenzhen) Co., Ltd. | 1 |
| Liverpool University Hospitals NHS Foundation Trust | 1 |
Interventions as named in the registry (3)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Contrast Enhanced Ultrasound (CEUS) | 2 |
| Definity Contrast | 1 |
| Doxycline | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Endoleak trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Gastrointestinal Disorders | 5 | 1 |
| Respiratory Disorders | 4 | 1 |
| Implant-Related Events | 3 | 1 |
| Supplemental Procedure | 3 | 1 |
| Vascular Disorders | 3 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Endoleak? (114)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Initial Clinical Experience With AneuFix Injectable Biocompatible Elastomer for Translumbar Embolization of Type 2 Endoleaks. | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists | 2025 | Yes |
| Side branch embolization before endovascular abdominal aortic aneurysm repair to prevent type II endoleak: A prospective multicenter study. | Diagnostic and interventional imaging | 2024 | Yes |
| Aortic aneurysm sac filling with AneuFix injectable polymer during endovascular aneurysm repair: feasibility and safety trial study protocol. | BMJ open | 2024 | Yes |
| Five-year outcomes of endosuture aneurysm repair in patients with short neck abdominal aortic aneurysm from the ANCHOR registry. | Journal of vascular surgery | 2023 | Yes |
| A preliminary analysis of late structural failures of the Navion stent graft in the treatment of descending thoracic aortic aneurysms. | Journal of vascular surgery | 2021 | Yes |
Showing 5 of 114 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.